Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment

OBJECTIVES: The objective of this study was to retrospectively evaluate neurologic status pre- and posttreatment with the oral farnesyltransferase inhibitor lonafarnib in children with Hutchinson-Gilford progeria syndrome (HGPS), a rare, fatal disorder of segmental premature aging that results in ea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ullrich, Nicole J., Kieran, Mark W., Miller, David T., Gordon, Leslie B., Cho, Yoon-Jae, Silvera, V. Michelle, Giobbie-Hurder, Anita, Neuberg, Donna, Kleinman, Monica E.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776537/
https://ncbi.nlm.nih.gov/pubmed/23897869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31829d85c0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados